Praxis Precision Medicines, Inc. (PRAX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -86.05M | -77.26M | -64.74M | -54.68M | -52.71M | -56.12M | -27.5M | -27.28M | -20.59M | -23.6M | -22.96M | -30.96M | -32.61M | -28.57M | -44.69M | -56.88M | -54.08M | -44.66M | -23.77M | -29.82M |
| Operating CF Margin % | - | - | - | - | - | -752% | -9105.96% | -7640.9% | -4776.33% | -4582.52% | -4906.2% | -3964.66% | -4773.94% | - | - | - | - | - | - | - |
| Operating CF Growth % | -63.26% | -37.66% | -135.41% | -100.44% | -156.03% | -137.81% | -19.77% | 11.9% | 36.86% | 17.4% | 48.63% | 45.57% | 39.71% | 36.02% | -88.03% | -90.72% | -111.78% | -122.78% | - | - |
| Net Income | -92.56M | -88.91M | -73.93M | -71.13M | -69.3M | -58.68M | -51.91M | -32.68M | -39.55M | -26.88M | -24.63M | -34.31M | -37.45M | -41.17M | -43.95M | -60.19M | -68.72M | -58.58M | -44.7M | -36.4M |
| Depreciation & Amortization | 39K | 28K | 19K | -941K | 47K | 47K | -3.53M | 107K | 112K | 111K | 321K | 312K | 307K | 301K | 292K | 305K | 273K | 563K | 506K | 319K |
| Stock-Based Compensation | 0 | 0 | 7.45M | 7.77M | 8.79M | 8.57M | 12.43M | 5.88M | 14.47M | 5.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 16.65M | 9.53M | -442K | 257K | -980K | -1.15M | 17.69M | -1.3M | 2.64M | 218K | 5.76M | 5.78M | 7.64M | 6.56M | 6.94M | 7.83M | 8.26M | 6.74M | 7.16M | 5.95M |
| Working Capital Changes | -10.18M | 2.09M | 2.17M | 9.37M | 8.74M | -4.92M | -2.18M | 715K | 1.74M | -2.78M | -4.41M | -2.74M | -3.1M | 5.74M | -7.98M | -4.83M | 6.1M | 6.62M | 13.27M | 303K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 6.53M | -6.19M | 1.99M | 5.92M | 10.38M | -2.48M | 7.01M | -1.4M | 3.59M | -1.3M | -894K | -8.98M | 2.31M | 4.55M | -1.7M | -1.45M | 2.49M | 3.24M | 323K | 1.5M |
| Cash from Investing | -344.27M | -328.39M | 50.41M | 17.89M | -51.06M | -10.92M | 49.57M | -195.92M | -91.22M | -50K | 0 | 5M | 34M | 22.59M | 47.95M | 34.89M | -8.55M | 10.17M | 13.55M | -24.23M |
| Capital Expenditures | -62K | 0 | 0 | -120K | 0 | 0 | 0 | 0 | 0 | -50K | 0 | 0 | 0 | 0 | -45K | -110K | -289K | -531K | -450K | -65K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | 9.71% | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 64K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 609.33M | 613.45M | 6.44M | 28.63M | 53.97M | 113.77M | 1.44M | 216.36M | 182.49M | 3.87M | -254K | 69.42M | 17.83M | 5.15M | 3.14M | 178K | 1.18M | 7.52M | 19K | 99.2M |
| Debt Issued (Net) | -101K | 933K | -319K | -311K | -303K | 835K | 0 | -278K | -271K | -261K | -254K | -250K | -240K | -233K | -226K | -326K | -26K | -197K | -193K | -188K |
| Equity Issued (Net) | 622.35M | 613.34M | 6.81M | 28.65M | 55.46M | 113.92M | 1.24M | 216.06M | 182.89M | 4.13M | 1K | 69.68M | 18.2M | 5.39M | 3.37M | 520K | 1.44M | 7.71M | 212K | 99.39M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -12.92M | -819K | -52K | 288K | -1.2M | -992K | 200K | 580K | -137K | -5K | -1K | -4K | -127K | -7K | -7K | -16K | -230K | 0 | 0 | 0 |
| Net Change in Cash | 179M | 207.8M | -7.89M | -8.15M | -49.8M | 46.73M | 23.5M | -6.84M | 70.68M | -19.79M | -23.21M | 43.46M | 19.22M | -825K | 6.4M | -21.82M | -60.85M | -27.57M | -10.62M | 45.14M |
| Free Cash Flow | -86.11M | -77.26M | -64.74M | -54.8M | -52.71M | -56.12M | -27.5M | -27.28M | -20.59M | -23.65M | -22.96M | -30.96M | -32.61M | -28.57M | -44.74M | -56.99M | -54.37M | -45.19M | -24.22M | -29.89M |
| FCF Margin % | - | - | - | - | - | -752% | -9105.96% | -7640.9% | -4776.33% | -4592.23% | -4906.2% | -3964.66% | -4773.94% | - | - | - | - | - | - | - |
| FCF Growth % | -63.38% | -37.66% | -135.41% | -100.88% | -156.03% | -137.3% | -19.77% | 11.9% | 36.86% | 17.23% | 48.68% | 45.67% | 40.03% | 36.77% | -84.72% | -90.68% | -112.88% | -125.43% | - | - |
| FCF per Share | -2.98 | -3.43 | -2.95 | -2.55 | -2.50 | -2.81 | -1.46 | -1.45 | -1.48 | -2.61 | -2.54 | -6.66 | -9.21 | -9.01 | -14.66 | -18.77 | -17.94 | -15.08 | -8.12 | -10.79 |
| FCF Conversion (FCF/Net Income) | 0.93x | 0.87x | 0.88x | 0.77x | 0.76x | 0.96x | 0.53x | 0.83x | 0.52x | 0.88x | 0.93x | 0.90x | 0.87x | 0.69x | 1.02x | 0.94x | 0.79x | 0.76x | 0.53x | 0.82x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |